Switzerland Committed to Innovation. The Swiss Network of Technology Assessment

Authors

  • Konrade von Bremen IEMS University of Lausanne, Lausanne, Switzerland
  • Maya Züllig Swiss Federal Office of Public Health Medical Technology Unit, Bern, Switzerland
  • Georg von Below Swiss Medical Association FMH, Bern, Switzerland
  • Felix Gurtner Swiss Federal Office of Public Health Medical Technology Unit, Bern, Switzerland
  • Christoph Künzli Swiss Federal Office of Public Health Medical Technology Unit, Bern, Switzerland
  • Sergio Bellucci Centre for Technology Assessment Swiss Science and Technology Council, Bern, Switzerland
  • Pedro Koch Swiss Federal Office of Public Health Medical Technology Unit, Bern, Switzerland

DOI:

https://doi.org/10.2427/5979

Keywords:

HTA, innovation, Switzerland, network

Abstract

Switzerland showed its commitment to innovation in health care since the early 80th
, implementing agencies
and government units with the mission to promote and to appropriately govern innovation. The Swiss
Network of Technology Assessment (SNHTA) was founded in 1998. The aim is the promotion and
implementation of Health Technology Assessment projects in Switzerland by providing a neutral forum for
the identification and the pursuit of common interests. This includes the coordination, exchange and
dissemination of experiences of HTA projects and the implementation of the results. The collaboration in
international projects is a priority. Ultimately SNHTA has the goal to improve efficacy, cost effectiveness and
social accountability. An inventory survey amongst the members confirmed a high level of diverse
specialised competencies, mainly employed within the institution. Only 20% of the HTA specific
competencies are used for external activities. The need for integration of all partners in the field of
innovation in a network has been recognised by the Swiss government. This lead to the creation of a
webplatform in which all players involved in the business of medical technologies are involved. This platform
(swiss medtech), includes patients, insurers, industry, universities and professional organisations. The
joined activities include agreements on intellectual property and the integrated patient care chain.
New ways to connect players in innovation are needed to face the challenge of increasing costs and
diminishing resources.

Downloads

Published

2005-06-30

Issue

Section

Theme Papers